Contrarian Corpus
Phrase library

Callouts & quotes from 37,061+ activist slides

Every emphasised callout and every pulled quote, extracted slide-by-slide. Search by keyword, filter by slide type or by source.

Showing 14461–14520 of 37,061
callout villain critique

"Did BP pretend to invest billions of Pounds in renewables without knowing how to present a permit plan, which complies with the law, or was Lightsource BP trying to circumvent the law?"

BP plc · BP Bluebell Capital · p. 9
callout demand list

"By way of illustration, a share buyback at a 61% discount(1) to NAV results in a 159% ROI in terms of increase in NAV per share setting a high benchmark for alternative uses of capital"

Samsung C&T Corporation · 028260 KS Palliser Capital · p. 38
callout villain critique

"It seems reasonable to conclude that hematocrit is intentionally omitted from the paper in order to avoid providing evidence that would undermine the claim to renal health improvement."

callout villain critique

"We believe that REZI's pre-tax income in the YTD 2025 period is inflated by 8-12% by making overly aggressive assumptions about the average customer life from the Snap One transaction."

Resideo Technologies, Inc. · REZI Spruce Point Capital · p. 77
callout ceo quote

"Executive indicated the paltry amounts of related-party revenue Ginkgo discloses from Synlogic does not square with the level of spending Synlogic is actually doing under the agreement"

Ginkgo Bioworks · DNA Scorpion Capital · p. 53
callout villain critique

"if Genomatica had to pay cash for Ginkgo’s R&D services, they would not do so – all but giving away the heart of the scam, that related-party “customers” are engaging in kabuki theater"

Ginkgo Bioworks · DNA Scorpion Capital · p. 60
callout villain critique

"The individual stated that Tantu “doesn’t have money to pay” Ginkgo for R&D services, so “the deal ended up being like a deferred loan, essentially, for the work they are going to do.”"

Ginkgo Bioworks · DNA Scorpion Capital · p. 113
callout other

"We observe inventory purchase obligations as a percentage of revenue increasing. This further strengthens our belief that inventory is building up and not selling-through to customers."

Prestige Consumer Healthcare Inc. · PBH Spruce Point Capital · p. 41
callout villain critique

"PHILLIPS 66’S CLAIMS OF SYNERGIES ACROSS THE COMPANY ARE 1) NOT ACTUAL SYNERGIES, 2) NORMAL COURSE FOR REFINING COMPETITORS AND 3) COULD BE REPLICATED THROUGH CONTRACTUAL ARRANGEMENTS."

Phillips 66 · PSX Elliott Management · p. 26
callout precedent table

"Spruce Point has a strong track record of exposing highly promoted industrial roll-ups and packaging companies before investors figure out that the businesses had inflected negatively."

Amcor plc · AMCR Spruce Point Capital · p. 3
callout villain critique

"LHCG disclosures regarding inorganic sales contributions from acquisitions seem to imply that Almost Family is not generating nearly the level of revenue that management first forecast"

LHC Group, Inc. · LHCG Spruce Point Capital · p. 14
callout other

"By writing down AFAM's tangible asset value and consistently booking inordinate acquisition-related expenses, LHCG management has wiped out nearly 15% of the paper value of the merger."

LHC Group, Inc. · LHCG Spruce Point Capital · p. 29
callout appendix disclosure

"ELLIOTT STRONGLY ADVISES ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION."

Commvault Systems, Inc. · CVLT Elliott Management · p. 15
callout ceo quote

"By Aerojet's own admission, backlog convertible to sales over the next 12 months is a leading indicator. Investors should, therefore, be cautioned that the metric closed 2018 at a low."

Aerojet Rocketdyne Holdings, Inc. · AJRD Spruce Point Capital · p. 25
callout cover

"If Kao focused on its Cosmetics and Health & Beauty Segments and improved marketing, Oasis believes its stock price would exceed JPY10,000 per share, a +76% upside from current levels."

Kao Corporation · 4452 JT Oasis Management · p. 1
callout sop buildup

"Despite attractive assets, Phillips' inefficient conglomerate structure means it trades near the multiple of its lowest-valued segments and at a discount to its sum-of-the-parts value."

Phillips 66 · PSX Elliott Management · p. 8
callout precedent table

"Independent analysis suggests that the U.S.'s $100 billion home-sale commission TAM could be reduced by as much as 30%-50% due to changes that will likely be brought on by the verdict."

Zillow Group, Inc. · Z Spruce Point Capital · p. 38
callout villain critique

"Flying in nonlocal teams "frequently" from other states, even when the donor and recipient are both in the same state and the entire process could be handled entirely by the local team"

TransMedics Group Inc · TMDX Scorpion Capital · p. 79
callout nominee bio

"The Transformation Committee's purpose is to: Make use of Board members' prior experience with corporate transformation (railroad and otherwise) to advise, guide, and coach management."

callout villain critique

"Given the substantial percentage of ad slots on Patch that we believe are sold at steep discounts to rate card pricing, we would also question whether national advertisers value Patch."

AOL, Inc. · AOL Starboard Value · p. 37
callout peer gap

"Does DOL – a value retailer demonstrating concerning fundamental trends – deserve to be valued on par with higher-growth industries, and completely out of line with its industry peers?"

Dollarama Inc. · DOL Spruce Point Capital · p. 50
callout peer gap

"Based on current implied run rate revenues of $297m, we estimate Leidos has paid 3.4x sales, or a substantial premium to benchmark deals in the airport security and detection industry."

Leidos Holdings, Inc. · LDOS Spruce Point Capital · p. 20
callout villain critique

"Moreover, this investigator comments cast grave doubt on the validity of the withdrawal study, which showed an abrupt spike in HQ-CT scores in the placebo group for such a “slow drug.”"

Soleno Therapeutics · SLNO Scorpion Capital · p. 337
callout villain critique

"ANTA has clearly lied in a material – and egregious – manner. Because of its control over its Tier 1 distributors’ finance departments, investors cannot rely on the ANTA brand numbers."

callout villain critique

"Insiders appear attuned to what's happening at the Company. Insider ownership has been in rapid decline post-IPO, in part from both insider selling and stock dilution for acquisitions."

Lightspeed Commerce, Inc. · LSPD Spruce Point Capital · p. 120
callout precedent table

"Spruce Point questions why would Lightspeed hire Nussey, an executive who went through a financial scandal and turnaround experience, to lead it through an IPO into the public markets?"

Lightspeed Commerce, Inc. · LSPD Spruce Point Capital · p. 115
callout villain critique

"Herbalife in China operates as it does in the rest of the world — as a pyramid scheme — violating the Direct-Sales Regulations, Pyramid Sales Regulations and the Criminal Law in China."

Herbalife Ltd. · HLF Pershing Square · p. 55
callout appendix methodology

"The purpose of adjustments to the final year is to reflect how the business will grow into perpetuity might be different from what the business looks like at the end of the final year."

N/A 99_Other · p. 55
callout villain critique

"Management revised unit costs four times in 2023. Poor execution has substantially eroded management's credibility and damaged Southwest’s competitive positioning as a low-cost carrier"

Southwest Airlines · LUV Elliott Management · p. 45
callout villain critique

"This disclosure shows Oxford Ionics knew they were going to get to the second round (receiving a total of $6 million) by July 2025, and they may have even known informally before then."

IonQ Inc · IONQ Wolfpack Research · p. 14
callout transition

"We believe MDLZ’s enormous efficiency opportunity exists because MDLZ was created through a series of acquisitions made by legacy Kraft that were never properly optimized or integrated"

callout peer gap

"In this report, we will detail our analysis of the available information and the reasons why believe that GSX is what most companies that are too good to be true end up being: a fraud."

GSX Techedu Inc. · GSX Grizzly Research · p. 6
callout villain critique

"The Lasertec machine’s throughput is so low that it can only inspect “five pieces per day” – referring to masks – while TSMC’s 5nm Fab 18 needs 550 masks inspected daily in production."

Lasertec Corporation · 6920 Scorpion Capital · p. 218
callout before after

"Since 2007, DSP has spent over $557 million, or $26.65 per share (vs. current price of $8.03), on R&D and acquisitions, yet revenue has declined by approximately 35% during this period"

DSP Group, Inc. · DSPG Starboard Value · p. 9
callout villain critique

"Fairness Opinions are valuation analyses that can be tailored considerably for a client by cherry-picking EBITDA figures, multiples and comparable figures to obtain the desired effect."

TPC Group Inc. · TPCG Sandell · p. 5
quote villain critique

"It appears obvious that the Board’s true intention with respect to the Preferred Financing was to “buy the vote” ahead of a potential election contest with Starboard. — Starboard Value"

Box, Inc. · BOX Starboard Value · p. 91
quote villain critique

""I've practiced urology for 30+ years. You could fill dumpsters w BPH solution technologies/companies. Nobody will remember this company in 3-5 years." — Urodoc on Seekingalpha, 9/6/24"

PROCEPT BioRobotics Corporation · PRCT Spruce Point Capital · p. 99
quote other

"in the net zero pathway, global energy demand in 2050 is around 8% smaller than today, but it serves an economy more than twice as big and a population with 2 billion more people — IEA"

BP plc · BP Bluebell Capital · p. 19
quote villain critique

"“Our 32-qubit system, which is an important milestone for our technical roadmap and commercialization, is not yet available for customers and may never be available.” — IonQ Prospectus"

IonQ Inc. · IONQ Scorpion Capital · p. 45
quote other

"The red lines in the above diagram illustrate the tissue that is ablated in a PVI procedure. — Source: Verma, A et al Approaches to Catheter Ablation for Persistent Atrial Fibrillation"

Acutus Medical Inc. · AFIB Kerrisdale Capital · p. 9
quote other

"Azure CDN Standard/Premium from Edgio (formerly Verizon) is still an active product offered by Azure and there are no updates of it being retired anytime soon. — Microsoft Q&A Platform"

Edgio, Inc. · EGIO Citron Research · p. 8
quote villain critique

"“Yeah...it was a word that was used. There was a remarkable amount of skepticism, which is why the response was patience. Let’s see how this plays out.” — IDT ex-regional sales manager"

Twist Bioscience · TWST Scorpion Capital · p. 30
quote ceo quote

"“CapEx for the quarter was $22 million, mostly associated with our Factory of the Future investment...We're investing about $40 million in Data Storage.” — James M. Thorburn, Twist CFO"

Twist Bioscience · TWST Scorpion Capital · p. 142
quote ceo quote

"“Also, we’re a very successful integrator of accretive acquisitions over the years, all of which have contributed to our growth in revenue and profits.” — 2011 Investor Forum (2/10/11)"

State Street Corporation · STT Trian Partners · p. 10
quote comparison table

"As intellectually dishonest as Analyst A’s projections appear, those of Analyst B and C seem more egregious, since they predict even higher revenues and commercialized products counts."

PeptiDream, Inc. · 4587 JP Muddy Waters · p. 21
quote villain critique

"According to the Israeli business supplement The Marker, Malka, the apparent settlor of the well-endowed family trust, lived in a "small, outdated apartment" that measured about 60 m2."

Vivion Investments Muddy Waters · p. 7
quote villain critique

"I have been disappointed by what I see as a breakdown of effective corporate governance at Phillips 66. — Energy veteran Greg Goff, former Andeavor CEO and Phillips 66 investor, 4/9/25"

Phillips 66 · PSX Elliott Management · p. 5
quote villain critique

"“be available to address shareholders’ concerns which have failed to be resolved by the chair, CEO or CFO or for which such contact is inappropriate” — BP Corporate Governance Document"

BP plc · BP Bluebell Capital · p. 1
quote villain critique

"I mean, we talked a little bit about bringing online terminals...now, our business model really remains asset light so, while the first couple of these we built, we — Sterling Anderson"

Aurora Innovation, Inc. · AUR Kerrisdale Capital · p. 36
quote other

"legacy declines are accelerating due to businesses transitioning to “mobile and cloud-based services at an accelerated rate as post-pandemic workplace restructuring takes hold.” — AT&T"

Lumen Technologies · LUMN Kerrisdale Capital · p. 8
quote villain critique

"Cambium is creating never-seen-before sustainable, ultra-high-performance biomaterials to address the most pressing challenges of the 21st century. — Cambium Biomaterials Press Release"

Ginkgo Bioworks · DNA Scorpion Capital · p. 109
quote precedent table

"The total consideration for NV5 is approximately $1.7 billion, representing approximately 10.3x 2025E consensus adjusted EBITDA. — Acuren Corporation and NV5 Global, Inc. Press Release"

Limbach Holdings, Inc. · LMB Spruce Point Capital · p. 85
quote villain critique

"Has TransMedics ever used private aircraft to transport staff and equipment without the purpose of transporting organs? — Congressman Paul Gosar letter to TransMedics CEO, Feb 21, 2024"

TransMedics Group Inc · TMDX Scorpion Capital · p. 46
quote villain critique

"“it’s probably that well-kept of a secret at this point...all those people have been interviewed....” — CEO of a major OPO (Organ Procurement Organization), longtime industry executive"

TransMedics Group Inc · TMDX Scorpion Capital · p. 122
quote villain critique

"Yeah, it's terrifying...because nobody ever answered that question of if something happens, then what...I definitely would have liked more training. — Former TransMedics OCS specialist"

TransMedics Group Inc · TMDX Scorpion Capital · p. 244
quote villain critique

"“CYP2D6 alleles tested and genotyping methods were appropriate for determining CYP2D6 PM [poor metabolizer] and NM [normal metabolizer] status.” — FDA CDER Clinical Pharmacology Review"

Harmony Biosciences Holdings · HRMY Scorpion Capital · p. 145
quote villain critique

"Bruce Linton, the CEO of Canopy Growth acknowledged in a recent interview on CNBC's Mad Money that the FDA has been clear that food including CBD it is not ready for human consumption."

New Age Beverage Corp. · NBEV Grizzly Research · p. 20
quote other

"Total Energie: https://www.amisdelaterre.org/communique-presse/total-condemned-for-greenwashing-a-major-legal-precedent-against-climate-misinformation-by-oil-majors/ — Amis de la Terre"

Accor SA · AC Grizzly Research · p. 50
quote villain critique

"“the plasma becomes unstable and brightness stability becomes worse...brightness may drop below the threshold required for mask inspection.” — 2023 SPIE presentations by Intel/Lasertec"

Lasertec Corporation · 6920 Scorpion Capital · p. 199